Lactobacillus helveticus

瑞士乳杆菌

Report date: 2024/09/06 14:51:38

Base Information

Drug NameLactobacillus helveticus
Drug Alias NameN/A
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsHelicobacter pylori infectionTrauma and Stressor Related DisordersDepressive Disorder, Major +[22] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[14] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesInstitut Rosell LallemandUniversità Degli Studi Di Bologna, ItalyPileje +[24] 
Inactive CompaniesMedical University Of LodzAuburn UniversityNational Center For Advancing Translational Sciences +[6] 
Active IndicationsHelicobacter pylori infectionTrauma and Stressor Related DisordersDepressive Disorder, Major +[18] 
Inactive IndicationsStress, PsychologicalMetabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A